An Israeli study of 10,621 women found that those taking an SSRI more than 80% of the time were 1.4 times more likely to experience bone fractures or to initiate treatment for osteoporosis. The study appeared online in CNS Drugs on May 21, 2012.
Zucker, I. Chodick, G. “Adherence to Treatment with Selective Serotonin Reuptake Inhibitors and the Risk for Fractures and Bone Loss: A Population-Based Cohort Study” CNS Drugs, published online May 21, 2012
